NCT00118937View on ClinicalTrials.gov

Effect of Metformin in Patients With Type-1 Diabetes With Inadequate Glycaemic Control by Insulin and Diet

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Metformin

Tablet Metformin 500 mg, Dosage: 1000 mg two times daily (2000 mg total daily dose).

DRUG

Placebo.

Tablet Placebo (corresponding to 500 mg metformin). Dosage: 1 tablet per day.

DRUG

Placebo.

Tablet Placebo (corresponding to 500 mg metformin). Dosage: 2 tablets two times daily.

All Listed Sponsors
lead

Steno Diabetes Center Copenhagen

OTHER

NCT00118937 - Effect of Metformin in Patients With Type-1 Diabetes With Inadequate Glycaemic Control by Insulin and Diet | Biotech Hunter | Biotech Hunter